WPC
UTHR icon

Wedmont Private Capital’s United Therapeutics UTHR Stock Holding History

Wedmont Private Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$958K Buy
1,751
+82
+5% +$46.2K 0.03% 361
2026
Q1 		$971K Hold
1,669
– – 0.03% 327
2025
Q4 		$841K Buy
1,669
+82
+5% +$38.2K 0.03% 332
2025
Q3 		$725K Buy
+1,587
New +$534K 0.03% 343
2025
Q1 		– Sell
-1,276
Closed -$466K – 767
2024
Q4 		$466K Buy
+1,276
New +$469K 0.02% 402

Other funds holding UTHR

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wedmont Private Capital's UTHR Position: Q2 2026 in Review

Wedmont Private Capital increased its United Therapeutics (UTHR) stake by 4.9% in Q2 2026, buying an estimated $46.2K and bringing the position to 1,751 shares worth $958K. The position accounts for 0.03% of the portfolio, ranked #361.

Wedmont Private Capital first reported a position in UTHR in Q4 2024 and has held it in 5 quarters since. The position peaked at $971K in Q1 2026. 96 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Wedmont Private Capital held 1,751 shares of United Therapeutics worth $958K as of Q2 2026.
  • Wedmont Private Capital bought 82 United Therapeutics shares in Q2 2026, an estimated $46.2K.
  • United Therapeutics made up 0.03% of Wedmont Private Capital's portfolio in Q2 2026, its #361 holding.
  • Wedmont Private Capital first reported a position in United Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Wedmont Private Capital's United Therapeutics position peaked at $971K in Q1 2026.
  • 96 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.